Motor cortex excitability in patients with migraine with aura and hemiplegic migraine

Autor: Jürgen Herzog, KJ Werhahn, K Wiseman, Martin Dichgans, Andreas Straube, S Foörderreuther

Publikováno v: Cephalalgia : an international journal of headache. 20(1)

We studied the excitability of the motor cortex using transcranial magnetic stimulation (TMS) in 12 patients with migraine with aura (MA) and nine patients with familial hemiplegic migraine (FHM). Motor thresholds at rest, the duration of the cortica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f0d5bc345809064adc0d097f3a215eb
https://pubmed.ncbi.nlm.nih.gov/10817446

Lacosamide and pregnancy: Data from spontaneous and solicited reports.

Autor: Perucca P; Epilepsy Research Centre, Department of Medicine (Austin Health), University of Melbourne, Melbourne, Victoria, Australia.; Bladin-Berkovic Comprehensive Epilepsy Program, Austin Health, Melbourne, Victoria, Australia., Bourikas D; UCB Pharma, Alimos, Greece., Voinescu PE; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Vadlamudi L; University of Queensland Centre for Clinical Research, University of Queensland, Herston, Queensland, Australia.; Department of Neurology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia., Chellun D; UCB Pharma, Braine-l'Alleud, Belgium., Kumke T; UCB Pharma, Monheim am Rhein, Germany., Werhahn KJ; UCB Pharma, Monheim am Rhein, Germany., Schmitz B; Vivantes Humboldt-Klinikum, Berlin, Germany.

Publikováno v: Epilepsia [Epilepsia] 2024 May; Vol. 65 (5), pp. 1275-1284. Date of Electronic Publication: 2024 Feb 27.

Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approach.

Autor: Muglia P; UCB Pharma, Braine l'Alleud, Belgium., Hannestad J; UCB Pharma, Braine l'Alleud, Belgium., Brandt C; Department of General Epileptology, Bethel Epilepsy Centre, Mara Hospital, Bielefeld, Germany., DeBruyn S; UCB Pharma, Braine l'Alleud, Belgium., Germani M; UCB Pharma, Braine l'Alleud, Belgium., Lacroix B; UCB Pharma, Braine l'Alleud, Belgium., Majoie M; Department of Neurology, Academic Center of Epileptology Kempenhaeghe, Maastricht University Medical Centre, Maastricht, The Netherlands., Otoul C; UCB Pharma, Braine l'Alleud, Belgium., Sciberras D; UCB Pharma, Braine l'Alleud, Belgium., Steinhoff BJ; Kork Epilepsy Center, Kehl-Kork, Germany., Van Laere K; Department of Imaging and Pathology, KU, Leuven, Belgium., Van Paesschen W; Department of Neurology, University Hospital, Leuven, Belgium., Webster E; UCB Pharma, Raleigh, NC, USA., Kaminski RM; UCB Pharma, Braine l'Alleud, Belgium., Werhahn KJ; UCB Pharma, Monheim am Rhein, Germany., Toledo M; Epilepsy Unit, Department of Neurology, Vall d'Hebron Hospital, Barcelona, Spain.

Publikováno v: Brain communications [Brain Commun] 2020 Nov 02; Vol. 2 (2), pp. fcaa183. Date of Electronic Publication: 2020 Nov 02 (Print Publication: 2020).

Safety and tolerability of lacosamide monotherapy in the elderly: A subgroup analysis from lacosamide trials in diabetic neuropathic pain.

Autor: Bainbridge J; University of Colorado Anschutz Medical Campus Skaggs School of Pharmacy and Pharmaceutical Sciences Aurora Colorado U.S.A., De Backer M; UCB Pharma Brussels Belgium., Eckhardt K; UCB Pharma Monheim am Rhein Germany., Tennigkeit F; UCB Pharma Monheim am Rhein Germany., Bongardt S; UCB Pharma Monheim am Rhein Germany., Sen D; UCB Pharma Raleigh North Carolina U.S.A., Werhahn KJ; UCB Pharma Monheim am Rhein Germany., Shaibani A; Nerve and Muscle Center of Texas Houston Texas U.S.A., Faught E; Emory University School of Medicine Atlanta Georgia U.S.A.

Publikováno v: Epilepsia open [Epilepsia Open] 2017 Sep 11; Vol. 2 (4), pp. 415-423. Date of Electronic Publication: 2017 Sep 11 (Print Publication: 2017).

Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.

Autor: Pohlmann-Eden B; Epilepsy Program, Division of Neurology, Queen Elizabeth II Health Science Center, Dalhousie University, Halifax, Canada. B.Pohlmann-Eden@dal.ca.; Brain Repair Center, Dalhousie University, Halifax, Canada. B.Pohlmann-Eden@dal.ca., Marson AG; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Noack-Rink M; UCB Pharma, Monheim am Rhein, Germany., Ramirez F; UCB Pharma, Monheim am Rhein, Germany., Tofighy A; UCB Pharma, Brussels, Belgium., Werhahn KJ; UCB Pharma, Monheim am Rhein, Germany., Wild I; UCB Pharma, Brussels, Belgium., Trinka E; Department of Neurology, Paracelsus Medical University, Christian Doppler Klinik, and Centre for Cognitive Neuroscience, Salzburg, Austria.

Publikováno v: BMC neurology [BMC Neurol] 2016 Aug 23; Vol. 16 (1), pp. 149. Date of Electronic Publication: 2016 Aug 23.